tiprankstipranks

John Hubbard Insider Profile

4 Followers
John Hubbard, Director at Agile Therapeutics, holds 0.00 shares in Science 37 (Ticker: SNCE), holds 976.00 shares in Agile Therapeutics (Ticker: AGRX).
tipranks
John Hubbard

John Hubbard
Agile Therapeutics (AGRX)
Director

Not Ranked
John Hubbard has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$309
100.00%
A breakdown of John Hubbard's holdings

Insider Roles

Agile Therapeutics
(AGRX)
Director
Roles that John Hubbard holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by John Hubbard

John Hubbard's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Agile Therapeutics
Jun 09, 2023
Director
Uninformative Buy
$309.39
SNCE
Science 37
Mar 12, 2024
Uninformative Sell
11.79K
$0.00
List of latest transactions for each holding click on a transaction to see John Hubbard's performance on stock

John Hubbard insider profile FAQ

What is the percentage of profitable transactions made by John Hubbard?
The percentage of profitable transactions made by John Hubbard is ―.
    What is the average return per transaction made by John Hubbard?
    The average return per transaction made by John Hubbard is ―.
      What stocks does John Hubbard hold?
      John Hubbard holds: AGRX, SNCE stocks.
        What was John Hubbard’s latest transaction?
        John Hubbard latest transaction was an Uninformative Sell of $11.79K.
          What was John Hubbard's most profitable transaction?
          John Hubbard’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is John Hubbard's role in Agile Therapeutics?
            John Hubbard's role in Agile Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.